Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers

NCT05075980 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05075980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05075980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 16, 2022
Completion date
March 5, 2031
Enrollment
174 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous squamous cell carcinoma of the head and neck, head and neck carcinoma, head and neck carcinoma of unknown primary, hypopharyngeal carcinoma, laryngeal carcinoma, locally advanced cutaneous squamous cell carcinoma of the head and neck, metastatic malignant neoplasm in the lymph nodes, nasal cavity carcinoma, oral cavity carcinoma, oropharyngeal carcinoma, paranasal sinus carcinoma, salivary gland carcinoma